10 Side Effects of Stopping Qsymia

If you are researching weight loss medications, you may be comparing GLP-1 receptor agonists and Qsymia as part of a comprehensive medical weight loss plan. Understanding how these medications influence appetite, hormonal balance, and nutrition is essential—as is recognizing the potential clinical effects of discontinuation, particularly if the medication is not tapered under professional supervision.

Many patients achieve positive clinical outcomes with Qsymia when used as a component of a whole-body metabolic strategy. At ShillMed in Spokane Valley, Dr. Shill helps patients look beyond the pill to prioritize sustainable weight loss, metabolic health, and habit development that support long-term success. If you are considering Qsymia or another medical weight loss options, evaluating possible side effects and contraindications can help you make a more informed decision.

This article has been reviewed by Dr. Shill.

What Is Qsymia?

Qsymia is an FDA-approved prescription weight loss medication indicated for adults with obesity or those who are overweight with at least one weight-related medical condition. It combines phentermine, which assists in appetite suppression, with topiramate, which influences satiety, cravings, and eating behavior. Because this medication affects the central nervous system and appetite regulation, it should only be initiated or discontinued under strict medical guidance.

Patients often ask whether Qsymia is similar to GLP-1 therapies. While both may be incorporated into medical weight loss plans, they belong to different pharmacological classes and work in different ways. The best therapeutic option for you depends upon your unique health history, current medications, and individual physiological response. This underscores why medically supervised care is fundamental to patient safety.*

10 Side Effects of Stopping Qsymia*

Stopping Qsymia can feel different for each person. Some people notice only a mild change, while others experience a more noticeable return of symptoms the medication had been helping manage. Below are 10 possible effects to know about.*

1. Increased appetite

One of the most common concerns after stopping Qsymia is a return of hunger. The medication may have been helping blunt appetite, so your usual cues can feel significantly stronger once it is discontinued. This can make it easier to eat larger portions or snack more often than expected, leading to weight regain.

2. Return of food cravings

Qsymia may effectively reduce cravings for high-calorie or highly processed foods. After stopping Qsymia, those cravings may reappear, especially if stress, sleep issues, or blood sugar swings are part of your daily pattern. This can feel discouraging, but it is a sign that the medication was supporting appetite control, rather than a personal failure.

3. Slower weight loss progress

Many patients find that their rate of weight loss slows after stopping Qsymia. In some cases, weight may stabilize for a time, while in others it may begin creeping upward if no new plan is in place. This is why transition planning is so important before making any medication change.

4. Weight regain

Weight regain can happen when appetite returns and old eating patterns come back without enough support. This does not happen to everyone, but it is a known possibility with the discontinuation of any medication that assists with appetite and satiety. A structured plan with nutrition coaching, behavior changes, and follow-up care can lower the risk.

5. Changes in energy

Some patients report feeling less energized after stopping Qsymia, especially if they were also relying on the medication's stimulant effect from phentermine. Fatigue can also occur if your calorie intake drops too low while you are on the medication and your body needs time to adjust. It helps to review sleep, hydration, protein intake, and physical activity during this transition.

6. Mood or motivation shifts

Because appetite, routine, and progress can affect mood, stopping Qsymia may lead to frustration, low motivation, or emotional eating for some individuals. These changes are not always caused by the medication directly, but they can happen when the structure it provided is no longer there. This is one reason ongoing support is so valuable during medical weight loss.

7. Headache or brain fog

Some people notice headaches, mental fog, or a sense of being less sharp after stopping Qsymia. This may be related to medication withdrawal, changes in caffeine use, or shifts in eating patterns. If symptoms are severe, prolonged, or accompanied by other concerns, your clinician should evaluate them promptly.

8. Digestive changes

When appetite and eating patterns change, digestion can change too. Some patients notice more constipation, bloating, or irregular bowel habits when they stop Qsymia, particularly if fiber, fluid intake, or meal timing have been inconsistent. A whole-body plan that includes gut health support can be helpful.

9. Return of emotional eating patterns

Qsymia may help create enough appetite control to make behavior changes easier, but it does not address the emotional and environmental triggers behind eating. Once the medication is stopped, stress eating, nighttime snacking, or boredom eating may become more noticeable again. This is one of the strongest arguments for pairing medication with coaching and accountability.

10. Rebound of weight-related symptoms

If Qsymia had been helping improve blood pressure, sleep quality, joint comfort, or blood sugar-related symptoms indirectly through weight loss, those benefits may fade if weight returns. This does not mean the medication caused harm, but rather that your underlying metabolic challenges still need attention. Long-term success depends on addressing the root causes, not just suppressing appetite.

*Because topiramate affects the nervous system, stopping the medication abruptly without medical guidance carries a risk of seizures. According to the Qsymia FDA prescribing Information, abrupt withdrawal of Qsymia, even in patients without a history of seizures, may precipitate seizures, which reinforces the necessity of a medically supervised taper. (See Qsymia FDA Prescribing Information, Sections 2.4, 5.12, 6, 9.3, 17, and Medication Guide)

Common Side Effects While Taking Qsymia

Since many people search about stopping Qsymia, it is also helpful to understand side effects that can occur while taking it. These may involve appetite, digestion, energy, mood, and nutrition. Not everyone experiences these effects, and many are manageable with the right dose and monitoring.

Appetite and weight-related side effects

Qsymia can reduce appetite, which is part of how it supports weight loss. For some patients, however, appetite reduction may become too strong and make it difficult to eat enough protein or balanced meals. Over time, under-eating can work against energy levels and nutrient status and even loss of muscle mass. 

Nutrition-related concerns

Because you may eat less on Qsymia, it can be harder to meet your needs for protein, fluids, fiber, and key micronutrients. Some patients also notice taste changes or reduced interest in food, which can further reduce intake. Monitoring nutrition is important so weight loss does not come at the expense of overall health. A Board-Certified Obesity physician will monitor your food intake and body composition to ensure you maintain ongoing metabolic health while on Qsymia.

Hormone and metabolic considerations

Weight loss medications can influence hunger hormones, stress response, and blood sugar patterns indirectly through changes in intake and body weight. In some people, those shifts can improve metabolic health. In others, especially if eating is too restricted, it may increase fatigue or make hormone-related symptoms feel more noticeable.

Who Should Not Take Qsymia?

Qsymia is not right for everyone. Certain medical conditions, medications, and life stages can make it unsafe or inappropriate, which is why a careful review is essential before prescribing. Your clinician should review your full history, current medications, and reproductive plans before you start.

• Pregnancy or plans to become pregnant, because Qsymia can cause serious birth defects.

• Uncontrolled glaucoma.

• Hyperthyroidism or other conditions where a stimulant-like medication may be risky.

• A history of certain heart issues or uncontrolled high blood pressure.

• Use of monoamine oxidase inhibitors, or MAOIs, within the past 14 days.

Caution is also required for individuals with a history of nephrolithiasis (kidney stones), mood disorders, seizure disorders, or sensitivity to stimulants. Consequently, a thorough medication review is a mandatory component of any medical weight loss program, not an afterthought, to ensure that patient safety remains the clinical priority.

Why a Whole-Body Approach Matters

Qsymia can be a helpful tool, but it is not a complete solution by itself. Long-term weight management works best when the plan includes nutrition guidance, sleep support, stress reduction, movement, and regular medical follow-up. That is especially true if appetite changes, hormonal shifts, or nutritional gaps become barriers.

At ShillMed in Spokane Valley, Dr. Shill takes a practical, patient-centered approach to obesity care. Rather than relying on medication alone, the goal is to help you build a plan that fits your body, your goals, and your lifestyle. That may include medication, but it also includes the support needed to make progress sustainable.

When to Talk to Your Clinician about GLP-1s

If you are thinking about stopping Qsymia, do not make the change on your own without asking your prescriber how to do it safely. It is especially important to reach out if you notice mood changes, strong rebound hunger, dizziness, headaches, or rapid weight regain. Your care team can help you decide whether to taper, switch medications, or reinforce your current weight loss plan.

Medical weight loss works best when it is individualized. If you are ready to explore whether Qsymia, a GLP-1, or another treatment may be appropriate for you, ShillMed can help guide the process with expert support and a whole-body strategy. Get started with a medical weight loss program here at ShillMed.

References

1. Allison DB, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330-342. https://doi.org/10.1038/oby.2011.330 

• Relevance: This is the landmark study establishing the efficacy of the phentermine/topiramate combination for weight loss, which supports your section on "What Is Qsymia?"

2. Garvey WT, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297-308. https://doi.org/10.3945/ajcn.111.024927 

• Relevance: This supports your points about long-term management and the "chronic disease" perspective of obesity treatment rather than viewing it as a quick fix.

3. American Association of Clinical Endocrinologists and American College of Endocrinology. Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3):1-203. https://doi.org/10.4158/EP161365.GL 

• Relevance: This guideline supports your emphasis on "whole-body strategies," including nutrition, lifestyle intervention, and the necessity of clinical monitoring as the gold standard for obesity management.